Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin a Nephropathy”

378 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 378 results

Large-scale testing (Phase 3)Study completedNCT02420821
What this trial is testing

Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche 915
Not applicableStudy completedNCT01560052
What this trial is testing

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)

Who this might be right for
IgA Glomerulonephritis
The George Institute 503
Not applicableStudy completedNCT01538433
What this trial is testing

A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 603
Testing effectiveness (Phase 2)Looking for participantsNCT06740526
What this trial is testing

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

Who this might be right for
IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 25
Early research (Phase 1)Not Yet RecruitingNCT07234474
What this trial is testing

A Phase I Study of YK012 in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Excyte Biopharma Ltd 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06687174
What this trial is testing

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Wuhan Createrna Science and Technology Co., Ltd 72
Large-scale testing (Phase 3)Study completedNCT00657059
What this trial is testing

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy
Sun Yat-sen University 151
Early research (Phase 1)Study completedNCT00625768
What this trial is testing

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Malignant Melanoma
Antisoma Research 13
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Post-approval studies (Phase 4)Ended earlyNCT02792413
What this trial is testing

Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease

Who this might be right for
Female With Osteoporosis and Chronic Kidney Disease
University Hospital, Montpellier 4
Large-scale testing (Phase 3)Ended earlyNCT03024996
What this trial is testing

Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche 778
Early research (Phase 1)Study completedNCT00923169
What this trial is testing

Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)

Who this might be right for
Renal Cell Carcinoma
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)UnknownNCT02886897
What this trial is testing

Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaBladder Cancer+3 more
Sun Yat-sen University 50
Testing effectiveness (Phase 2)WithdrawnNCT00311545
What this trial is testing

S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Early research (Phase 1)Ended earlyNCT00520533
What this trial is testing

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)
Ludwig Institute for Cancer Research 8
Post-approval studies (Phase 4)Study completedNCT00498368
What this trial is testing

Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgA Nephropathy
Mayo Clinic 34
Post-approval studies (Phase 4)UnknownNCT01758120
What this trial is testing

Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 135
Very early researchLooking for participantsNCT06792799
What this trial is testing

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Load More Results